• search
About Us About Us

About Us

Our clients recognize us as a leading - CRO/CDMO and long-term partner working together towards accelerating the journey from ideas to medicines.

Introduction

We are an agile and dynamic team, committed to impacting people's lives by accelerating drug discovery, development and manufacturing. Aurigene Pharmaceutical Services is your CRO/CDMO for end-to-end capabilities across drug discovery, development and manufacturing of APIs and formulations. More than two decades of experience in accelerating breakthrough discoveries for global pharma and biotech companies position us well to understand the challenges and find solutions to bring your products to the market faster.

We have integrated discovery, development and manufacturing operations in most of the technology platforms including cytotoxic APIs, carbohydrates, steroids, PEG derivatives, prostaglandins and peptides. In addition, we run discovery scale and CDMO scale operations in biotherapeutics services such as ADCs, mAbs, mRNAs and CAR Ts.     

Our focus on scientific expertise, technology, innovation and problem solving along with our strong fundamentals on sustainability, compliance and IP security have made us a preferred partner across many large pharma and biotech companies. We believe in fostering and nurturing long-term partnerships through our work built on speed, adaptability, clarity of communication and collaboration.

Aurigene's Legacy

2002

Dr. Reddy’s Custom Pharmaceutical Services was founded for contract development and manufacturing

2004

2004-Dr. Reddy’s Custom Pharmaceutical Services became a CDMO partner for top 3 innovator pharma clients

2005

Aurigene Discovery Technologies Limited was founded to serve the discovery customer

2007

Aurigene Discovery Technologies Limited established long-term FTE business with a top big pharma client

2010

Dr. Reddy’s Custom Pharmaceutical Services won multi-year commercial contracts with big pharma and large CDMO clients

2020

Services arm of Aurigene Discovery Technologies Limited and Dr. Reddy’s Custom Pharmaceutical Services integrated to form Aurigene Pharmaceutical Services Limited.

2022

We are a 700+ scientist organization supporting 125+ global clients and 500+ projects

Our Leadership Team

Akhil Ravi

Akhil Ravi

Chief Executive Officer

donearrow

Akhil Ravi is Chief Executive Officer (CEO) of Aurigene Pharmaceutical Services.

Before joining Aurigene Pharmaceutical Services from Dr. Reddy’s Laboratories on February 1, 2022, Akhil has served as Head of strategy for services and Active Pharmaceutical Ingredients (APIs), Head of API sales in Europe, and as plant head at one of Dr. Reddy’s manufacturing sites.

Akhil holds a B.Tech degree in Chemical engineering from IIT Bombay and an MBA from the Indian School of Business (ISB).

Kapil Choudhury

Kapil Choudhury

Head, Global Business Development

donearrow

Kapil Choudhury is Global Head of Sales and Business Development for Aurigene and is responsible for shaping the commercial strategy for Aurigene. Kapil has nearly two decades of experience in Strategy, R&D + Manufacturing Operations, Partnerships and Country Management across Pharma, Services and Consulting spaces.

Prior to joining Aurigene, Kapil was Global Head of Business Development, Alliance Management Portfolio and Product Management at Dr. Reddy’s. Kapil led Dr. Reddy’s global covid response team, which was responsible for bringing full spectrum of COVID solutions to India, including India’s third approved Viral Vector Platform based vaccine and a concurrent effort along with Merck to bring Molnupiravir to India. Kapil was awarded ET Business Leader of the year by world HRD congress in 2021 for his notable contributions for fighting COVID. Kapil also worked as engagement manager at IQVIA prior to joining Dr. Reddy’s.

Kapil is alumnus of prestigious Fergusson College, India and INSEAD Business School, France. Kapil is a member of Healthcare Academic advisory committee of IIM, IIT and AIIMS Jammu. Kapil also frequently mentors students at SOIL & IIFT and is passionate about youth skill development from rural and semi urban centers of India.

Roger Lias

Roger Lias

Global Head Commercial, Biologics

donearrow

Dr. Roger Lias is a globally recognized expert in and advocate for the biologics CDMO marketplace. Roger started his career during market making periods with Celltech/Lonza and Diosynth before joining founding management teams at KBI Biopharma, Cytovance Biologics and Eden Biodesign. More recently Roger has served as CEO at Stelis Biopharma and at Avid Bioservices (NASDAQ:CDMO) and was instrumental in the sale of Vibalogics to Recipharm in 2022. At Aurigene Roger is responsible for all commercial functions supporting our Discovery and CDMO service offering in the biologics space. He serves in an advisory capacity in support of several industry groups and organizations.

Dr. Gayathri Ramaswamy

Dr. Gayathri Ramaswamy

Global Head, Discovery Services

donearrow

Dr. Gayathri Ramaswamy is the Global Head of Discovery Services at Aurigene.

Dr. Gayathri joined us from Intergalactic Therapeutics, where she served as Vice President & Head of Drug Discovery and Disease Biology. Prior to Intergalactic, she held leadership positions at Biogen and Pfizer.

Dr. Gayathri has extensive experience in several therapeutic areas including neuroscience and ophthalmology, across different modalities such as small molecule, large molecule, and non-viral gene therapy. She is an expert in brain-lipid metabolism, apolipoprotein E and its role in Alzheimer’s disease.

Gayathri holds a PhD in Biochemistry St. Jude Children’s Research Hospital, University of Tennessee, Memphis, and completed her post-doctoral training at the Gladstone Institute of Neurological Diseases, University of California, San Francisco. She currently serves as a Scientific Advisory Board member for a lipid-biology focused start-up biotech based in Cambridge, Massachusetts.

Chetan Pandit

Chetan Pandit

Chief Scientific Officer

donearrow

Chetan received his PhD in synthetic organic chemistry from State University of New York at Buffalo and has over 20 years of experience in synthetic, process and medicinal chemistry in industries spanning across the globe. Chetan has experience in leading multi-disciplinary discovery and developmental teams that have delivered several preclinical and clinical candidates. He has experience in working with various target classes including Proteases, Kinases, NHR’s and Epigenetics. across different therapeutic areas of Oncology, Pain and Inflammation and Metabolic disorders. He has more than 30 patents and publications to his credit and is affiliated with Aurigene since April 2007.

Dr. Srividya Ramakrishnan

Dr. Srividya Ramakrishnan

Global Head of CDMO

donearrow

Dr. Srividya joined us as a Global Head of CDMO drug substance business. She has over 22+ years of rich experience in process engineering, flow chemistry, continuous manufacturing, polymorph screening, crystallization process development and process analytical technologies. She has been associated with Dr. Reddy’s Laboratories, Bristol-Myers Squibb, and Unilever before joining us in 2024. She has a PhD in chemical engineering from Princeton University and a B.Tech from the Indian Institute of Technology, Madras.

Sangamesh Badiger

Sangamesh Badiger

Operations Head, Small Molecule Discovery Services

donearrow

Sangamesh received his PhD in synthetic organic chemistry from Gulbarga University, Kalaburgi, Karnataka. He has over two decades of synthetic and medicinal chemistry research experience with several renowned indian pharma companies. Sangamesh has extensive experience in drug discovery projects in metabolic disorders, inflammation, oncology and neuroscience areas. Sangamesh has co-authored 14 publications in peer-reviewed journals and co-invented 12 patents.

Priyaranjan Pattanaik

Priyaranjan Pattanaik

Head, NBE Services

donearrow

Dr. Priyaranjan Pattanaik heads the NBE division at Aurigene Pharmaceutical Services Limited, engaged with discovery and development of large molecule drugs and critical bio-reagents. Priyaranjan is a structural biologist with ~18 years of experience in industry and academia. Priyaranjan has led many large molecule discovery collaborations with innovator pharma companies involving antibodies, ADC, mRNA and bi-specific modalities that have resulted in development and clinical candidates. Priyaranjan is passionate about new technologies and their application in accelerating progression of drug candidates from concept to clinic. As a business leader engaged with global clientele, Priyaranjan believes in a people-centric approach to successful collaborations underpinned by transparent communication, high integrity and a shared vision of bringing new therapies to patients faster and in a cost effective way.

Priyaranjan received his Ph. D from Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), Bangalore. He carried out post-doctoral research in Medical School of Case Western Reserve University at Cleveland, Ohio, USA on structure based NCE discovery against bacterial antibiotic resistance.

Ashutosh Kotwal

Ashutosh Kotwal

Chief Human Resource Officer

donearrow

Ashutosh Kotwal is a Head HR and Admin with Aurigene Pharmaceutical Services Ltd. In the current role he is responsible to formulate HR strategy aligned to organization strategy and create performance driven culture in the organization. Ashutosh has more than 20 years of rich experience spread across various sectors like pharmaceutical, FMCG and engineering. He brings with him expertise in providing HR leadership at strategic as well as operations level in the areas of HR business partnering, talent and performance management, compensation and benefits and employee relations. He has spearheaded various assignments or projects like setting up HR business partnering organization for India commercial organization, organization restructuring, digitalization of employee life cycle operations, talent management, restructuring of compensation and benefits across multiple organizations, setting up HRIS system for multi divisional organization etc. Before taking up the current role, Ashutosh was heading all HR CoEs for global manufacturing operations for Dr. Reddy’s Laboratories Ltd. Prior to joining Dr. Reddy’s Laboratories Ashutosh was associated with different organizations where he has handled several roles with increasing responsibility. Ashutosh has a master’s degree in Labor Studies from MILS, Mumbai

Vinoth Kumar

Vinoth Kumar

Head, Supply Chain and Logistics

donearrow

Vinoth has over 21 years of experience in supply chain operations which includes strategic sourcing, contract manufacturing, material management and technology transfer activities across pharmaceutical industries. Vinoth is a chemical engineer and holds MBA in pharma management and operations management. He has also obtained PhD in management (SCM). He has many publications in peer reviewed journals to his credit.

Atul Sachdeva

Atul Sachdeva

Chief Financial Officer

donearrow

Atul has 14+ years of rich experience in business finance, investments, and financial performance management across pharmaceutical industry as well as private equity organizations. Atul holds MBA Finance from International Management Institute and B Tech Electronics from Institute of Technology Management. Atul is responsible for driving finance, legal and compliance function at Aurigene.

PVR Bharadwaja

PVR Bharadwaja

Head, Marketing and Strategy

donearrow

PVR joins us from Dr. Reddy’s Laboratories and has over 15 years of experience spanning across various functions including business strategy and planning, R and D, business development, alliance management and management consulting.

Before moving to Aurigene, he was part of Dr. Reddy’s commercial API team as the head of BD and portfolio management. PVR holds PGDM from IIM Kozhikode and B Tech in Mechanical Engineering from IIT Madras.

Satyanarayan Giri

Satyanarayan Giri

Head - SHE, Safety Health and Environment

donearrow

Satyanarayan is an EHS and sustainability professional with 19 years of cross industry experience. Satyanarayan is a Chemical engineer and holds advanced diploma in Industrial Safety from Mumbai University. He is a PMP certified professional and has professional certifications in GMMP, Lean Six Sigma, Dupont safety training and Ergonomics.

Suresh Juluri

Suresh Juluri

Head, Preclinical Services

donearrow

Suresh has 22+ years of rich experience in drug discovery and functional service. In his past roles, he has worked in leadership roles in in vivo Pharmacology and Toxicology fields. Suresh holds PhD from Department of Animal Sciences - University of Hyderabad and Masters in Sciences - Biotechnology, SV University Tirupathi.

Suresh is responsible for driving Discovery Biology Services team to achieve long term and short term organizational priorities.

Dr. Rajesh Vooturi

Dr. Rajesh Vooturi

Head, Formulation R and D

donearrow

Rajesh joins Aurigene from Dr. Reddy’s Laboratories and has over 21+ years of rich experience in the industry. Before moving to Aurigene, he was part of API commercial team and was working as a Program Manager- API Plus.

Rajesh holds Ph.D. in Pharmaceutical Technology from University College of Pharmaceutical Sciences, Kakatiya University and M. Pharm (Pharmaceutics) from BITS Pilani, Rajasthan.

Rajesh is responsible for heading the FR and D Space to ensure delivery of formulation development and technology transfer projects and achieve long term and short term organizational priorities.

Our infrastructure

R and D centers

Aurigene Pharmaceutical Services is well-equipped with laboratories from discovery to clinical phase III for NCEs and NBEs. We operate two state-of-the-art R and D centers in Bangalore and Hyderabad. Our R and D centers are equipped with 60+ modular laboratories to handle highly potent substances, peptides, oligonucleotides etc. Our facility also has an extensive analytical center of excellence in addition to special purpose labs for safety assessment studies and polymorphism studies. Our best-in-class discovery biology services are supported by AAALAC accredited vivarium, BSL-2 compliant labs, in vivo facilities, GLP and other regulatory bodies accredited toxicology labs. Our state-of-the-art preclinical evaluation safety facility has been inspected by FCPSA Netherlands, DCGI and is annually inspected by National GLP Compliance Monitoring Authority (NGCMA). Our facility has also been inspected by the US FDA and the quality systems in this facility are in accordance with NGCMA and US FDA standards.

Manufacturing facilities

We have access to cGMP manufacturing facilities in the UK, Mexico and India. We operate thousands of kilo liters of API capacities that can handle various range of chemistries from regular small molecules, peptides, potent compounds, steroids, carbohydrates and pegylated drugs. In addition, we also operate formulation manufacturing plants that can handle various dosage forms including oral solids, parenteral and topical. Our facilities are designed modularly and offer flexibility of scale, enabling efficient operations. Our manufacturing facilities are regularly inspected by regulatory agencies.

Sustainability

We prioritise sustainability in everything we undertake. At Aurigene Pharmaceutical Services we constantly strive to build sustainable operations by avoiding accidents through safety compliance, minimize environmental impact through stringent standards and enhance health of employees through sustainable operating philosophy.                    

Aurigene Pharmaceutical services has a long-standing commitment to safety and sustainability. We have been early pioneers in adopting the sustainability in our operations and have consistently set ourselves ambitious targets in favor of renewable energy, water positivity, waste management and biodiversity.

FY24 APSL annual action plan CSR policy ISO certificate for Environmental Management System ISO certificate for Occupational Health and Safety Management System Biomedical Waste Report

Life at Aurigene

Our employees, who are constantly striving to set new benchmarks, are at the core of our success. We hire and retain the best in class talent. We foster growth of our employees with curated learning journeys and support their aspirations to help them achieve different milestones. We encourage and support innovative ideas to help employees grow and improve their skill set. Our flagship program 'Prarambh' is designed to commence the professional journey and support an enriching scientific career. Our 'Prarambh 2022' batch is a women-only batch that is focusing on Biotherapeutics services.

We strike a good balance between work and life in order to achieve our full potential. We come together to make festivals, events and other special achievements memorable.

client

Aruna N

Scientist, Medicinal Chemistry

Working at Aurigene encouraged me to grow both professionally and personally. The work environment nurtures excellence and rewards innovation, alongside a culture of safety and security. I also appreciate the opportunity to regularly participate in technical and scientific trainings and that the senior scientists and leaders are extremely supportive and willing to share their knowledge and experience.

client

Sridhar Regati, Ph.D

Senior Scientist, Process R&D

As a member of the R&D team, I feel proud and passionate as I am surrounded by innovative minds, and have the opportunities to contribute to the development of various projects for our global customers. Each new project has its unique challenges and I thoroughly enjoy the learning opportunities presented by each project. Each function at Aurigene Pharmaceutical services has subject matter experts and I always look forward to our cross functional meetings where we plan together and work as a team to ensure that desired results are always delivered.

 
  • client
  • client
×

You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.

If you wish to continue to this external website, click Proceed.

ProceedBack